Impacto do câncer residual após quimioterapia neoadjuvante e desfechos de sobrevida de longo prazo no câncer de mama: análise multicêntrica de 5.161 pacientes. 4 Fev, 2022 | 15:42h Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients – The Lancet Oncology Comentário: Long-Term Outcomes According to Residual Cancer Burden After Neoadjuvant Chemotherapy for Breast Cancer – The ASCO Post